Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting.

Sci Adv · 2021 · PMC7997521 · PMID 33771865

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

near-significantP = 0.051so close (0.05 < p ≤ 0.1)

Further monitoring after stopping the treatment in MOLP-8 xenografts revealed a near-significant prolonged delay in tumor growth during the week after the last treatment ( P = 0.051) (fig.

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.